Global initiative for chronic obstructive lung diseases (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseases. National institutes of health national heart, lung and Blood institute, Update. GOLD. 2023.
Chen W, Thomas J. Sadatsafavi M, Fitz FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015; 3(8): 631-9.
Pascoe S, Locantore N, D Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 3(6): 435-42.
Bafadhel M, Peterson S, De Blas MA. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018; 6(2): 117-26.
Hartl S, Breyer MK, Burghuber OC. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020; 55(5): 1901874.
Kolsum U, South T, Jackson N, Singh D. Blood eosinophil counts in COPD patients compared to controls. Eur Respir J. 2019; 54(4): 1900633
Li J, Sun S, Tang R. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016; 11: 3079-91.
Suissa , Dell'Aniello S, Ernst P. Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice. Chest. 2019; 155(6): 1158-65.
Walters JA JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014; (9): CD001288
Saeki M, Kaminuma O, Nishimura T, Kitamura N, Mori A, Hiroi T. Th9 Cells Elicit Eosinophil Independent Bronchial Hyperresponsiveness in Mice. Allergol Int. 2016; 65 (Suppl): S24–S29.
Erry P. Korelasi Antara Eosinofil Darah Dan Sputum Pasien Penyakit Paru Obstruksi Kronik (PPOK) Di Rumah Sakit Rujukan Respirasi Nasional Persahabatan. Jakarta. 2019.
Kang. The association between eosinofilic ecxacerbation and eosinophilic level in stable COPD. BMC Pulmonary Medicine. 2021; 1:1.
Kim VL, Coombs NA, Staples KJ, Ostridge KK, Williams NP, Wootton SA. et al. Impact and associations of eosinophilic infammation in COPD: analysis of the AERIS cohort. Eur Respir J. 2017; 50 (4): 1700853.
Hesagawa K, Camargo C. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Repirology. 2016. 21(4): 761- 764
Barnes PJ. Similarities and differences in inflammatory mechanisms of asthma and COPD. Breathe. 2011;7(3):229–38
Lukawska JJ, Livieratos L, Sawyer BM, Lee T, O’Doherty M, Blower PJ, et al. Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo. EBioMedicine. 2014; 1 (2): 173–180.
Carverley PM, Rabe KF, Goehring UM. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009; 374 (9691): 685-94
Bruselle G, Price D, Gruffydd-Jones K. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis. 2015; 10: 2207-17.
Cazzola M, Molimard M. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD. Pulm Pharmacol Ther. 2010; 23(4): 257-67.
Pellegrino R, Viegi G, Brusasco V. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5): 948-68.
Cho SH, Lin HC, Ghoshal AG. Respiratory disease in the Asia-Pacific region: Cough as a key symptom. AllergyAsthma Proc. 2016; 37(2): 131-40.
Laviollete L, Laveneziana P, Faculty ERSRS. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014; 43(6): 1750-62.
Celli BR, BR, Fabbri LM, Aaron SD. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med. 2021; 204(11): 1251-8.
Cho MH, Hobbs BD, Silverman EK. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respir Med. 2022; 10(5): 485-96.